Evaluation of rituximab therapy in real clinical practice (according to the OREL registry of patients with rheumatoid arthritis

Evaluation of rituximab therapy in real clinical practice (according to the OREL registry of patients with rheumatoid arthritis

Objective: to analyze therapy with rituximab (RTM) in real clinical practice according to the data available in OREL registry of patients with active rheumatoid arthritis (RA).Subjects and methods. The analysis included 349 patients. All the patients received RTM: 340 – the original drug (MabThera®)...

Full description

Bibliographic Details
Main Authors: A. S. Avdeeva, A. M. Satybaldyev, N. V. Demidova, N. Yu. Nikishina, E. V. Gerasimova, N. V. Muravyeva, G. I. Gridneva, O. A. Rumyantseva, K. A. Kasumova, A. V. Alekseeva, N. V. Chichasova, D. A. Kusevich, V. V. Rybakova, E. A. Koshkarova, A. M. Lila, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2019-07-01
Series:Научно-практическая ревматология
Subjects:
rheumatoid arthritis
orel registry
real clinical practice
rituximab
Online Access:https://rsp.mediar-press.net/rsp/article/view/2725

Internet

https://rsp.mediar-press.net/rsp/article/view/2725

Similar Items